BTMD Stock Analysis: Buy, Sell, or Hold?
BTMD - Biote Corp. Class A Common Stock
$2.29
0.04 (1.78%)
▲
5d:
-1.72%
30d:
+5.53%
90d:
+4.57%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 05, 2026
TODAY
Get Alerted When BTMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BTMD shows positive signals but monitor for confirmation. Market pricing in 7.4% growth. Moderate conviction.
💡 BUY OPPORTUNITY: BTMD shows positive signals but monitor for confirmation. Market pricing in 7.4% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$3.28
Based on 12.7% avg growth
INTRINSIC VALUE TODAY
$2.04
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 3.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BTMD is currently trading at $2.29, which is considered fair relative to its 30-day fair value range of $2.02 to $2.41. From a valuation perspective, the stock is trading at a premium (Forward PE: 4.0) compared to its historical average (3.2). At these levels, the market is pricing in 7.4% annual earnings growth.
Technical Outlook: Technically, BTMD is in a strong uptrend. Immediate support is located at $1.98, while resistance sits at $2.60.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.73 (+19.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BTMD is in a strong uptrend. Immediate support is located at $1.98, while resistance sits at $2.60.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.73 (+19.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.02 -
$2.41
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.3%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($2.73)
- BULLISH: Expecting earnings turnaround to 7.4% growth with -8.3% revenue growth
Trading Range Analysis
30-Day Trading Range
$2.02 -
$2.41
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.98
Resistance Level
$2.60
Current Trend
Strong Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
4.02
Wall Street Target
$2.73
(+19.3%)
Revenue Growth (YoY)
-8.3%
Earnings Growth (YoY)
-83.8%
Profit Margin
8.3%
Valuation Premium vs History
+7.4% premium
PE vs Historical
4.0 vs 3.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+7.4%
(market-implied from PE analysis)
1-Year Target
$2.46
(+7%)
2-Year Target
$2.64
(+15%)
3-Year Target
$2.84
(+24%)
3-Yr Target (if PE normalizes)
(PE: 4→3)
PE COMPRESSION
$2.26
(-1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 21.3%)
$21.08
(+820%)
Base:
(SPY PE: 4.0, Growth: 21.3%)
$4.08
(+78%)
Bear:
(PE: 3.2, Growth: 21.3%)
$3.25
(+42%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (5x PE), but valuation improves significantly next year (4x PE) as earnings recover.
Trailing PE: 5.23 | Current EPS (TTM): $0.43
Bull Case
$3.28
(+43%)
Analyst growth 32.6%, PE expands to 5.8
Base Case
$2.98
(+30%)
Market implied 32.6%, PE stable at 5.2
Bear Case
$1.53
(-33%)
Severe decline -20.0%, PE contracts to 4.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 04, 2026 4:19 AM ET
Data refreshes hourly during market hours. Next update: 5:19 AM
Data refreshes hourly during market hours. Next update: 5:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BTMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$277 | 52 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$453 | 47 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 46 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$33 | 61 BUY |
